The content on this site is intended for healthcare professionals only
Prof Catharine West discusses RAPPER, a national effort amongst radiotherapists at the University of Manchester and Cambridge University to collect and profile samples from radiotherapy patients from across the UK. The aim of the project is to discover the long term risk of toxicity in patients and create risk profiles. This profiling will help determine which patients are less susceptible to the side effects of radiotherapy, allowing dosage to be increased and improve control of the disease.
Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma
ASCO 2024: Lung cancer highlights
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy
Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal cancer
Transoral surgery and neck dissection with deintensified risk-based post-operative management increases efficacy in oropharynx cancer
Maintenance systemic therapy versus local consolidative therapy plus maintenance systemic therapy for NSCLC
Multiple myeloma in a resource constrained setting
The evolving paradigm in management of Multiple Myeloma
2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab
